aluates Reports

$ 0.0

Automative

Veterinary Vaccine Adjuvants- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Published Date: August 2025

Report Code: QYRE-Auto-4Y9119

Global Veterinary Vaccine Adjuvants Market Outlook 2022

BUY CHAPTERS

Veterinary Vaccine Adjuvants- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-4Y9119

Report

August 2025

Pages:101

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

SEPPIC

SDA BIO

SPI Pharma

CRODA

Phibro Animal Health

Vertellus

Veterinary Vaccine Adjuvants- Market Size

The global market for Veterinary Vaccine Adjuvants was estimated to be worth US$ 345 million in 2024 and is forecast to a readjusted size of US$ 548 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.

Veterinary Vaccine Adjuvants- Market

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

Global 5 largest manufacturers of Veterinary Vaccine Adjuvants are SEPPIC, Croda, Vertellus, SPI Pharma and SDA BIO, which make up about 70%. Among them, SEPPIC is the leader with about 35% market share.

North America is the largest market, with a share over 30%, followed by Asia-Pacific and Europe, with the share about 30% and 22%. In terms of product type, Emulsion Adjuvants occupy the largest share of the total market, about 58%. And in terms of application, the largest application is Livestock Vaccines, followed by Companion Animals Vaccines.

This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine Adjuvants, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Veterinary Vaccine Adjuvants by region & country, by Type, and by Application.

The Veterinary Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (K L) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine Adjuvants.

Market Segmentation

Scope of Veterinary Vaccine Adjuvants- Market Report

Report Metric	Details
Report Name	Veterinary Vaccine Adjuvants- Market
Forecasted market size in 2031	US$ 548 million
CAGR	6.9%
Forecasted years	2025 - 2031
Segment by Type	Emulsion Adjuvants Mineral Adjuvants Others
Segment by Application	Livestock Vaccines Companion Animals Vaccines
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	SEPPIC, SDA BIO, Croda, SPI Pharma, Phibro Animal Health, Vertellus
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Veterinary Vaccine Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Veterinary Vaccine Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Veterinary Vaccine Adjuvants in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Veterinary Vaccine Adjuvants- Market size in 2031?

Ans: The Veterinary Vaccine Adjuvants- Market size in 2031 will be US$ 548 million.

What is the SEPPIC, Croda, Vertellus, SPI Pharma, SDA BIO share in Veterinary Vaccine Adjuvants- Market?

Ans: Global 5 largest manufacturers of Veterinary Vaccine Adjuvants are SEPPIC, Croda, Vertellus, SPI Pharma and SDA BIO, which make up about 70%.

What is the SEPPIC share in Veterinary Vaccine Adjuvants- Market?

Ans: Among them, SEPPIC is the leader with about 35% market share.

What is the Veterinary Vaccine Adjuvants- Market share by region?

Ans: North America is the largest market, with a share over 30%, followed by Asia-Pacific and Europe, with the share about 30% and 22%.

What is the Veterinary Vaccine Adjuvants- Market share by type?

Ans: In terms of product type, Emulsion Adjuvants occupy the largest share of the total market, about 58%.

Who are the main players in the Veterinary Vaccine Adjuvants- Market report?

Ans: The main players in the Veterinary Vaccine Adjuvants- Market are SEPPIC, SDA BIO, Croda, SPI Pharma, Phibro Animal Health, Vertellus

What are the Application segmentation covered in the Veterinary Vaccine Adjuvants- Market report?

Ans: The Applications covered in the Veterinary Vaccine Adjuvants- Market report are Livestock Vaccines, Companion Animals Vaccines

What are the Type segmentation covered in the Veterinary Vaccine Adjuvants- Market report?

Ans: The Types covered in the Veterinary Vaccine Adjuvants- Market report are Emulsion Adjuvants, Mineral Adjuvants, Others

Recommended Reports

Veterinary Vaccines

Animal Health Products

Adjuvants & Additives

1 Market Overview

1.1 Veterinary Vaccine Adjuvants Product Introduction

1.2 Global Veterinary Vaccine Adjuvants Market Size Forecast

1.2.1 Global Veterinary Vaccine Adjuvants Sales Value (2020-2031)

1.2.2 Global Veterinary Vaccine Adjuvants Sales Volume (2020-2031)

1.2.3 Global Veterinary Vaccine Adjuvants Sales Price (2020-2031)

1.3 Veterinary Vaccine Adjuvants Market Trends & Drivers

1.3.1 Veterinary Vaccine Adjuvants Industry Trends

1.3.2 Veterinary Vaccine Adjuvants Market Drivers & Opportunity

1.3.3 Veterinary Vaccine Adjuvants Market Challenges

1.3.4 Veterinary Vaccine Adjuvants Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Veterinary Vaccine Adjuvants Players Revenue Ranking (2024)

2.2 Global Veterinary Vaccine Adjuvants Revenue by Company (2020-2025)

2.3 Global Veterinary Vaccine Adjuvants Players Sales Volume Ranking (2024)

2.4 Global Veterinary Vaccine Adjuvants Sales Volume by Company Players (2020-2025)

2.5 Global Veterinary Vaccine Adjuvants Average Price by Company (2020-2025)

2.6 Key Manufacturers Veterinary Vaccine Adjuvants Manufacturing Base and Headquarters

2.7 Key Manufacturers Veterinary Vaccine Adjuvants Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Veterinary Vaccine Adjuvants

2.9 Veterinary Vaccine Adjuvants Market Competitive Analysis

2.9.1 Veterinary Vaccine Adjuvants Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Veterinary Vaccine Adjuvants Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine Adjuvants as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Emulsion Adjuvants

3.1.2 Mineral Adjuvants

3.1.3 Others

3.2 Global Veterinary Vaccine Adjuvants Sales Value by Type

3.2.1 Global Veterinary Vaccine Adjuvants Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Veterinary Vaccine Adjuvants Sales Value, by Type (2020-2031)

3.2.3 Global Veterinary Vaccine Adjuvants Sales Value, by Type (%) (2020-2031)

3.3 Global Veterinary Vaccine Adjuvants Sales Volume by Type

3.3.1 Global Veterinary Vaccine Adjuvants Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Veterinary Vaccine Adjuvants Sales Volume, by Type (2020-2031)

3.3.3 Global Veterinary Vaccine Adjuvants Sales Volume, by Type (%) (2020-2031)

3.4 Global Veterinary Vaccine Adjuvants Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Livestock Vaccines

4.1.2 Companion Animals Vaccines

4.2 Global Veterinary Vaccine Adjuvants Sales Value by Application

4.2.1 Global Veterinary Vaccine Adjuvants Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Veterinary Vaccine Adjuvants Sales Value, by Application (2020-2031)

4.2.3 Global Veterinary Vaccine Adjuvants Sales Value, by Application (%) (2020-2031)

4.3 Global Veterinary Vaccine Adjuvants Sales Volume by Application

4.3.1 Global Veterinary Vaccine Adjuvants Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Veterinary Vaccine Adjuvants Sales Volume, by Application (2020-2031)

4.3.3 Global Veterinary Vaccine Adjuvants Sales Volume, by Application (%) (2020-2031)

4.4 Global Veterinary Vaccine Adjuvants Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Veterinary Vaccine Adjuvants Sales Value by Region

5.1.1 Global Veterinary Vaccine Adjuvants Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Veterinary Vaccine Adjuvants Sales Value by Region (2020-2025)

5.1.3 Global Veterinary Vaccine Adjuvants Sales Value by Region (2026-2031)

5.1.4 Global Veterinary Vaccine Adjuvants Sales Value by Region (%), (2020-2031)

5.2 Global Veterinary Vaccine Adjuvants Sales Volume by Region

5.2.1 Global Veterinary Vaccine Adjuvants Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Veterinary Vaccine Adjuvants Sales Volume by Region (2020-2025)

5.2.3 Global Veterinary Vaccine Adjuvants Sales Volume by Region (2026-2031)

5.2.4 Global Veterinary Vaccine Adjuvants Sales Volume by Region (%), (2020-2031)

5.3 Global Veterinary Vaccine Adjuvants Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Veterinary Vaccine Adjuvants Sales Value, 2020-2031

5.4.2 North America Veterinary Vaccine Adjuvants Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Veterinary Vaccine Adjuvants Sales Value, 2020-2031

5.5.2 Europe Veterinary Vaccine Adjuvants Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Veterinary Vaccine Adjuvants Sales Value, 2020-2031

5.6.2 Asia Pacific Veterinary Vaccine Adjuvants Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Veterinary Vaccine Adjuvants Sales Value, 2020-2031

5.7.2 South America Veterinary Vaccine Adjuvants Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Veterinary Vaccine Adjuvants Sales Value, 2020-2031

5.8.2 Middle East & Africa Veterinary Vaccine Adjuvants Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Veterinary Vaccine Adjuvants Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Veterinary Vaccine Adjuvants Sales Value

6.2.1 Key Countries/Regions Veterinary Vaccine Adjuvants Sales Value, 2020-2031

6.2.2 Key Countries/Regions Veterinary Vaccine Adjuvants Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Veterinary Vaccine Adjuvants Sales Value, 2020-2031

6.3.2 United States Veterinary Vaccine Adjuvants Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Veterinary Vaccine Adjuvants Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Veterinary Vaccine Adjuvants Sales Value, 2020-2031

6.4.2 Europe Veterinary Vaccine Adjuvants Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Veterinary Vaccine Adjuvants Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Veterinary Vaccine Adjuvants Sales Value, 2020-2031

6.5.2 China Veterinary Vaccine Adjuvants Sales Value by Type (%), 2024 VS 2031

6.5.3 China Veterinary Vaccine Adjuvants Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Veterinary Vaccine Adjuvants Sales Value, 2020-2031

6.6.2 Japan Veterinary Vaccine Adjuvants Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Veterinary Vaccine Adjuvants Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Veterinary Vaccine Adjuvants Sales Value, 2020-2031

6.7.2 South Korea Veterinary Vaccine Adjuvants Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Veterinary Vaccine Adjuvants Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Veterinary Vaccine Adjuvants Sales Value, 2020-2031

6.8.2 Southeast Asia Veterinary Vaccine Adjuvants Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Veterinary Vaccine Adjuvants Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Veterinary Vaccine Adjuvants Sales Value, 2020-2031

6.9.2 India Veterinary Vaccine Adjuvants Sales Value by Type (%), 2024 VS 2031

6.9.3 India Veterinary Vaccine Adjuvants Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 SEPPIC

7.1.1 SEPPIC Company Information

7.1.2 SEPPIC Introduction and Business Overview

7.1.3 SEPPIC Veterinary Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 SEPPIC Veterinary Vaccine Adjuvants Product Offerings

7.1.5 SEPPIC Recent Development

7.2 SDA BIO

7.2.1 SDA BIO Company Information

7.2.2 SDA BIO Introduction and Business Overview

7.2.3 SDA BIO Veterinary Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 SDA BIO Veterinary Vaccine Adjuvants Product Offerings

7.2.5 SDA BIO Recent Development

7.3 Croda

7.3.1 Croda Company Information

7.3.2 Croda Introduction and Business Overview

7.3.3 Croda Veterinary Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Croda Veterinary Vaccine Adjuvants Product Offerings

7.3.5 Croda Recent Development

7.4 SPI Pharma

7.4.1 SPI Pharma Company Information

7.4.2 SPI Pharma Introduction and Business Overview

7.4.3 SPI Pharma Veterinary Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 SPI Pharma Veterinary Vaccine Adjuvants Product Offerings

7.4.5 SPI Pharma Recent Development

7.5 Phibro Animal Health

7.5.1 Phibro Animal Health Company Information

7.5.2 Phibro Animal Health Introduction and Business Overview

7.5.3 Phibro Animal Health Veterinary Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Phibro Animal Health Veterinary Vaccine Adjuvants Product Offerings

7.5.5 Phibro Animal Health Recent Development

7.6 Vertellus

7.6.1 Vertellus Company Information

7.6.2 Vertellus Introduction and Business Overview

7.6.3 Vertellus Veterinary Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Vertellus Veterinary Vaccine Adjuvants Product Offerings

7.6.5 Vertellus Recent Development

8 Industry Chain Analysis

8.1 Veterinary Vaccine Adjuvants Industrial Chain

8.2 Veterinary Vaccine Adjuvants Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Veterinary Vaccine Adjuvants Sales Model

8.5.2 Sales Channel

8.5.3 Veterinary Vaccine Adjuvants Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

SEPPIC

SDA BIO

SPI Pharma

CRODA

Phibro Animal Health

Vertellus

List of Tables

Table 1. Veterinary Vaccine Adjuvants Market Trends

Table 2. Veterinary Vaccine Adjuvants Market Drivers & Opportunity

Table 3. Veterinary Vaccine Adjuvants Market Challenges

Table 4. Veterinary Vaccine Adjuvants Market Restraints

Table 5. Global Veterinary Vaccine Adjuvants Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Veterinary Vaccine Adjuvants Revenue Market Share by Company (2020-2025)

Table 7. Global Veterinary Vaccine Adjuvants Sales Volume by Company (2020-2025) & (K L)

Table 8. Global Veterinary Vaccine Adjuvants Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Veterinary Vaccine Adjuvants Price by Company (2020-2025) & (USD/L)

Table 10. Key Manufacturers Veterinary Vaccine Adjuvants Manufacturing Base and Headquarters

Table 11. Key Manufacturers Veterinary Vaccine Adjuvants Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Veterinary Vaccine Adjuvants

Table 13. Global Veterinary Vaccine Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine Adjuvants as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Veterinary Vaccine Adjuvants Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Veterinary Vaccine Adjuvants Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Veterinary Vaccine Adjuvants Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Veterinary Vaccine Adjuvants Sales Market Share in Value by Type (2020-2025)

Table 20. Global Veterinary Vaccine Adjuvants Sales Market Share in Value by Type (2026-2031)

Table 21. Global Veterinary Vaccine Adjuvants Sales Volume by Type: 2020 VS 2024 VS 2031 (K L)

Table 22. Global Veterinary Vaccine Adjuvants Sales Volume by Type (2020-2025) & (K L)

Table 23. Global Veterinary Vaccine Adjuvants Sales Volume by Type (2026-2031) & (K L)

Table 24. Global Veterinary Vaccine Adjuvants Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Veterinary Vaccine Adjuvants Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Veterinary Vaccine Adjuvants Price by Type (2020-2025) & (USD/L)

Table 27. Global Veterinary Vaccine Adjuvants Price by Type (2026-2031) & (USD/L)

Table 28. Global Veterinary Vaccine Adjuvants Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Veterinary Vaccine Adjuvants Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Veterinary Vaccine Adjuvants Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Veterinary Vaccine Adjuvants Sales Market Share in Value by Application (2020-2025)

Table 32. Global Veterinary Vaccine Adjuvants Sales Market Share in Value by Application (2026-2031)

Table 33. Global Veterinary Vaccine Adjuvants Sales Volume by Application: 2020 VS 2024 VS 2031 (K L)

Table 34. Global Veterinary Vaccine Adjuvants Sales Volume by Application (2020-2025) & (K L)

Table 35. Global Veterinary Vaccine Adjuvants Sales Volume by Application (2026-2031) & (K L)

Table 36. Global Veterinary Vaccine Adjuvants Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Veterinary Vaccine Adjuvants Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Veterinary Vaccine Adjuvants Price by Application (2020-2025) & (USD/L)

Table 39. Global Veterinary Vaccine Adjuvants Price by Application (2026-2031) & (USD/L)

Table 40. Global Veterinary Vaccine Adjuvants Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Veterinary Vaccine Adjuvants Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Veterinary Vaccine Adjuvants Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Veterinary Vaccine Adjuvants Sales Value by Region (2020-2025) & (%)

Table 44. Global Veterinary Vaccine Adjuvants Sales Value by Region (2026-2031) & (%)

Table 45. Global Veterinary Vaccine Adjuvants Sales Volume by Region (K L): 2020 VS 2024 VS 2031

Table 46. Global Veterinary Vaccine Adjuvants Sales Volume by Region (2020-2025) & (K L)

Table 47. Global Veterinary Vaccine Adjuvants Sales Volume by Region (2026-2031) & (K L)

Table 48. Global Veterinary Vaccine Adjuvants Sales Volume by Region (2020-2025) & (%)

Table 49. Global Veterinary Vaccine Adjuvants Sales Volume by Region (2026-2031) & (%)

Table 50. Global Veterinary Vaccine Adjuvants Average Price by Region (2020-2025) & (USD/L)

Table 51. Global Veterinary Vaccine Adjuvants Average Price by Region (2026-2031) & (USD/L)

Table 52. Key Countries/Regions Veterinary Vaccine Adjuvants Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Veterinary Vaccine Adjuvants Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Veterinary Vaccine Adjuvants Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Veterinary Vaccine Adjuvants Sales Volume, (2020-2025) & (K L)

Table 56. Key Countries/Regions Veterinary Vaccine Adjuvants Sales Volume, (2026-2031) & (K L)

Table 57. SEPPIC Company Information

Table 58. SEPPIC Introduction and Business Overview

Table 59. SEPPIC Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)

Table 60. SEPPIC Veterinary Vaccine Adjuvants Product Offerings

Table 61. SEPPIC Recent Development

Table 62. SDA BIO Company Information

Table 63. SDA BIO Introduction and Business Overview

Table 64. SDA BIO Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)

Table 65. SDA BIO Veterinary Vaccine Adjuvants Product Offerings

Table 66. SDA BIO Recent Development

Table 67. Croda Company Information

Table 68. Croda Introduction and Business Overview

Table 69. Croda Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)

Table 70. Croda Veterinary Vaccine Adjuvants Product Offerings

Table 71. Croda Recent Development

Table 72. SPI Pharma Company Information

Table 73. SPI Pharma Introduction and Business Overview

Table 74. SPI Pharma Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)

Table 75. SPI Pharma Veterinary Vaccine Adjuvants Product Offerings

Table 76. SPI Pharma Recent Development

Table 77. Phibro Animal Health Company Information

Table 78. Phibro Animal Health Introduction and Business Overview

Table 79. Phibro Animal Health Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)

Table 80. Phibro Animal Health Veterinary Vaccine Adjuvants Product Offerings

Table 81. Phibro Animal Health Recent Development

Table 82. Vertellus Company Information

Table 83. Vertellus Introduction and Business Overview

Table 84. Vertellus Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)

Table 85. Vertellus Veterinary Vaccine Adjuvants Product Offerings

Table 86. Vertellus Recent Development

Table 87. Key Raw Materials Lists

Table 88. Raw Materials Key Suppliers Lists

Table 89. Veterinary Vaccine Adjuvants Downstream Customers

Table 90. Veterinary Vaccine Adjuvants Distributors List

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Veterinary Vaccine Adjuvants Product Picture

Figure 2. Global Veterinary Vaccine Adjuvants Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Veterinary Vaccine Adjuvants Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Veterinary Vaccine Adjuvants Sales Volume (2020-2031) & (K L)

Figure 5. Global Veterinary Vaccine Adjuvants Sales Price (2020-2031) & (USD/L)

Figure 6. Veterinary Vaccine Adjuvants Report Years Considered

Figure 7. Global Veterinary Vaccine Adjuvants Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Veterinary Vaccine Adjuvants Players Sales Volume Ranking (2024) & (K L)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Veterinary Vaccine Adjuvants Revenue in 2024

Figure 10. Veterinary Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Emulsion Adjuvants Picture

Figure 12. Mineral Adjuvants Picture

Figure 13. Others Picture

Figure 14. Global Veterinary Vaccine Adjuvants Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 15. Global Veterinary Vaccine Adjuvants Sales Value Market Share by Type, 2024 & 2031

Figure 16. Global Veterinary Vaccine Adjuvants Sales Volume by Type (2020 VS 2024 VS 2031) & (K L)

Figure 17. Global Veterinary Vaccine Adjuvants Sales Volume Market Share by Type, 2024 & 2031

Figure 18. Global Veterinary Vaccine Adjuvants Price by Type (2020-2031) & (USD/L)

Figure 19. Product Picture of Livestock Vaccines

Figure 20. Product Picture of Companion Animals Vaccines

Figure 21. Global Veterinary Vaccine Adjuvants Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 22. Global Veterinary Vaccine Adjuvants Sales Value Market Share by Application, 2024 & 2031

Figure 23. Global Veterinary Vaccine Adjuvants Sales Volume by Application (2020 VS 2024 VS 2031) & (K L)

Figure 24. Global Veterinary Vaccine Adjuvants Sales Volume Market Share by Application, 2024 & 2031

Figure 25. Global Veterinary Vaccine Adjuvants Price by Application (2020-2031) & (USD/L)

Figure 26. North America Veterinary Vaccine Adjuvants Sales Value (2020-2031) & (US$ Million)

Figure 27. North America Veterinary Vaccine Adjuvants Sales Value by Country (%), 2024 VS 2031

Figure 28. Europe Veterinary Vaccine Adjuvants Sales Value, (2020-2031) & (US$ Million)

Figure 29. Europe Veterinary Vaccine Adjuvants Sales Value by Country (%), 2024 VS 2031

Figure 30. Asia Pacific Veterinary Vaccine Adjuvants Sales Value, (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Veterinary Vaccine Adjuvants Sales Value by Region (%), 2024 VS 2031

Figure 32. South America Veterinary Vaccine Adjuvants Sales Value, (2020-2031) & (US$ Million)

Figure 33. South America Veterinary Vaccine Adjuvants Sales Value by Country (%), 2024 VS 2031

Figure 34. Middle East & Africa Veterinary Vaccine Adjuvants Sales Value, (2020-2031) & (US$ Million)

Figure 35. Middle East & Africa Veterinary Vaccine Adjuvants Sales Value by Country (%), 2024 VS 2031

Figure 36. Key Countries/Regions Veterinary Vaccine Adjuvants Sales Value (%), (2020-2031)

Figure 37. Key Countries/Regions Veterinary Vaccine Adjuvants Sales Volume (%), (2020-2031)

Figure 38. United States Veterinary Vaccine Adjuvants Sales Value, (2020-2031) & (US$ Million)

Figure 39. United States Veterinary Vaccine Adjuvants Sales Value by Type (%), 2024 VS 2031

Figure 40. United States Veterinary Vaccine Adjuvants Sales Value by Application (%), 2024 VS 2031

Figure 41. Europe Veterinary Vaccine Adjuvants Sales Value, (2020-2031) & (US$ Million)

Figure 42. Europe Veterinary Vaccine Adjuvants Sales Value by Type (%), 2024 VS 2031

Figure 43. Europe Veterinary Vaccine Adjuvants Sales Value by Application (%), 2024 VS 2031

Figure 44. China Veterinary Vaccine Adjuvants Sales Value, (2020-2031) & (US$ Million)

Figure 45. China Veterinary Vaccine Adjuvants Sales Value by Type (%), 2024 VS 2031

Figure 46. China Veterinary Vaccine Adjuvants Sales Value by Application (%), 2024 VS 2031

Figure 47. Japan Veterinary Vaccine Adjuvants Sales Value, (2020-2031) & (US$ Million)

Figure 48. Japan Veterinary Vaccine Adjuvants Sales Value by Type (%), 2024 VS 2031

Figure 49. Japan Veterinary Vaccine Adjuvants Sales Value by Application (%), 2024 VS 2031

Figure 50. South Korea Veterinary Vaccine Adjuvants Sales Value, (2020-2031) & (US$ Million)

Figure 51. South Korea Veterinary Vaccine Adjuvants Sales Value by Type (%), 2024 VS 2031

Figure 52. South Korea Veterinary Vaccine Adjuvants Sales Value by Application (%), 2024 VS 2031

Figure 53. Southeast Asia Veterinary Vaccine Adjuvants Sales Value, (2020-2031) & (US$ Million)

Figure 54. Southeast Asia Veterinary Vaccine Adjuvants Sales Value by Type (%), 2024 VS 2031

Figure 55. Southeast Asia Veterinary Vaccine Adjuvants Sales Value by Application (%), 2024 VS 2031

Figure 56. India Veterinary Vaccine Adjuvants Sales Value, (2020-2031) & (US$ Million)

Figure 57. India Veterinary Vaccine Adjuvants Sales Value by Type (%), 2024 VS 2031

Figure 58. India Veterinary Vaccine Adjuvants Sales Value by Application (%), 2024 VS 2031

Figure 59. Veterinary Vaccine Adjuvants Industrial Chain

Figure 60. Veterinary Vaccine Adjuvants Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Biological Vaccines Adjuvants Market Research Report 2025

Global Mineral based Adjuvants Market Research Report 2024

Immunostimulatory Adjuvants Market

Global Adjuvanted Influenza Vaccine Market Research Report 2024

Global Dog Vaccines Market Insights Forecast to 2030

Global Oral Vaccine Adjuvants Market Research Report 2025

Veterinary Vaccine Market

Global Veterinary Vaccination Market Research Report 2025

Global Travelers Vaccination Market Research Report 2025

Global Travelers Vaccines Market Research Report 2025

Global Livestock Vaccines Market Research Report 2025

Global Human Vaccination Market Research Report 2025

Global Oncology Adjuvants Market Insights Forecast to 2030

Global Intramuscular Vaccine Adjuvants Market Research Report 2025

Global Livestock Animal Vaccination Market Research Report 2025

Global Livestock Animal Vaccines Market Research Report 2024

Global Cat Vaccines Market Insights Forecast to 2030

Global Veterinary Biological Vaccines Market Research Report 2025

Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions